GO:0008934 inositol monophosphate 1-phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008934 describes the molecular function of catalyzing the hydrolysis of 1D-myo-inositol 1-phosphate to myo-inositol and phosphate [1,2].
• This activity is critical for inositol recycling and phosphatidylinositol signaling, and is inhibited by lithium, a mood stabilizer used in bipolar disorder.
• Enzymes with this activity include inositol monophosphatase and inositol polyphosphate 1-phosphatase, which are structurally conserved and often require magnesium or zinc ions for catalysis [1,3,4].
• Dysregulation of inositol monophosphate 1-phosphatase activity has been linked to neurological and psychiatric disorders, and it is a target for drug development [2,6].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of gene function and disease mechanisms related to this activity.
• Studying this activity requires a combination of biochemical assays, structural biology, and advanced molecular techniques such as CRISPR screening and bioinformatics [3,4,5].
Description
Inositol monophosphate 1-phosphatase activity (GO:0008934) is a molecular function that catalyzes the hydrolysis of 1D-myo-inositol 1-phosphate to myo-inositol and phosphate [1,2]. This reaction is a key step in the phosphatidylinositol signaling pathway and inositol recycling, processes essential for cellular signal transduction, membrane trafficking, and osmotic regulation [2,6]. Researchers study this activity to understand its role in neuronal signaling, lithium sensitivity, and various diseases, including bipolar disorder and cancer [2,6]. The enzyme responsible, inositol monophosphatase, is a magnesium-dependent phosphatase that is inhibited by lithium, making it a target for mood stabilizers. Structural studies have revealed conserved active-site residues and metal-binding motifs that are critical for catalysis [3,4]. Understanding GO:0008934 at the molecular level provides insights into how cells maintain inositol homeostasis and how perturbations contribute to disease.
inositol monophosphate 1-phosphatase activity At A Glance
| GO ID | GO:0008934 |
|---|---|
| GO term | inositol monophosphate 1-phosphatase activity |
| Ontology | molecular_function |
| Synonym | inositol-1(or 4)-monophosphatase activity; inositol 1-phosphatase activity; L-myo-inositol-1-phosphate phosphatase activity; myo-inositol-1(or 4)-monophosphatase activity; myo-inositol-1(or 4)-phosphate phosphohydrolase activity; myo-inositol 1-phosphatase activity; myo-inositol-1-phosphatase activity |
| Major function | Catalyzes the hydrolysis of 1D-myo-inositol 1-phosphate to myo-inositol and phosphate |
| Reaction | 1D-myo-inositol 1-phosphate + H2O = myo-inositol + phosphate |
| Cofactors | Magnesium or zinc ions (depending on enzyme) |
| Inhibitors | Lithium, calcium, manganese |
| Localization | Cytoplasm |
What Is GO:0008934?
GO:0008934 is defined as the catalysis of the reaction: 1D-myo-inositol 1-phosphate + H2O = myo-inositol + phosphate. In other words, it is the enzymatic removal of a phosphate group from inositol monophosphate, producing free inositol and inorganic phosphate. This activity is synonymous with inositol-1(or 4)-monophosphatase activity, inositol 1-phosphatase activity, and several other names listed in QuickGO. It is a molecular function that resides in the cytoplasm and is involved in inositol metabolism and signal transduction.
Why Is inositol monophosphate 1-phosphatase activity Important in Cell Biology?
Inositol monophosphate 1-phosphatase activity is essential for maintaining cellular inositol levels and for the proper functioning of the phosphatidylinositol signaling cascade, which regulates diverse processes such as cell growth, differentiation, and neurotransmission [2,6]. Its inhibition by lithium is a well-established mechanism for mood stabilization in bipolar disorder, highlighting its clinical relevance. Moreover, alterations in this activity have been implicated in cancer, neurodegeneration, and developmental disorders, making it a promising target for therapeutic intervention [6,8].
• Regulates inositol recycling and phosphatidylinositol signaling, critical for cell signaling and membrane dynamics.
• Target of lithium, a first-line treatment for bipolar disorder.
• Involved in neuronal development and function; dysregulation linked to psychiatric and neurodegenerative diseases.
• Plays a role in osmotic stress responses and cell survival.
• Structural conservation across species enables model organism studies [3,4].
• Enzymes with this activity are potential drug targets for cancer and neurological disorders [6,8].
• Provides a paradigm for understanding metal-dependent phosphatase mechanisms [1,4].
• CRISPR-based models allow precise manipulation for functional studies.
What Happens During inositol monophosphate 1-phosphatase activity?
Substrate Binding and Metal Coordination
In simple terms: The enzyme grabs the inositol phosphate molecule and uses metal ions to help break the phosphate bond.
The enzyme binds 1D-myo-inositol 1-phosphate in its active site, where conserved residues coordinate a metal ion, typically magnesium or zinc, that activates a water molecule for nucleophilic attack [1,4]. Structural studies of inositol polyphosphate 1-phosphatase from bovine brain and Entamoeba histolytica have revealed that the active site contains a binuclear metal center that stabilizes the substrate and facilitates catalysis [3,4,5].
Catalytic Hydrolysis
In simple terms: The enzyme cuts the phosphate group off the inositol ring, releasing free inositol and phosphate.
Upon substrate binding, the metal-activated water molecule attacks the phosphorus atom, leading to the cleavage of the phosphoester bond and release of myo-inositol and inorganic phosphate [2,4]. This reaction is dependent on the presence of divalent cations, and the enzyme exhibits optimal activity at neutral pH.
Product Release and Recycling
In simple terms: The products are released, and the free inositol can be reused to make new signaling lipids.
After catalysis, myo-inositol and phosphate are released from the active site. The free inositol is then available for reincorporation into phosphatidylinositol, replenishing the pool of signaling lipids [2,6]. This recycling is crucial for sustained phosphatidylinositol signaling and cellular responses.
Regulation by Lithium and Other Ions
In simple terms: Lithium blocks the enzyme, which is how it works as a mood stabilizer.
Lithium ions inhibit inositol monophosphate 1-phosphatase activity by competing with magnesium for binding to the active site, leading to uncompetitive inhibition. Other ions such as calcium and manganese also modulate activity, and the enzyme's sensitivity to these ions varies among isoforms and species [2,7].
Key Genes Involved in GO:0008934 inositol monophosphate 1-phosphatase activity
The following genes encode enzymes with inositol monophosphate 1-phosphatase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IMPA1 | Inositol monophosphatase 1; catalyzes hydrolysis of inositol monophosphate | Target of lithium; linked to bipolar disorder and neuronal function [2,6] |
| IMPA2 | Inositol monophosphatase 2; similar activity to IMPA1 | Associated with schizophrenia and bipolar disorder |
| IMPA3 | Inositol monophosphatase 3; involved in inositol recycling | Potential role in metabolic disorders |
| INPP1 | Inositol polyphosphate 1-phosphatase; hydrolyzes inositol 1,4-bisphosphate and other polyphosphates | Regulates phosphatidylinositol signaling; inhibited by lithium [2,4] |
| ITPA | Inosine triphosphatase; can hydrolyze inositol polyphosphates | May have overlapping substrate specificity |
| BPNT1 | 3'(2'),5'-bisphosphate nucleotidase; dual activity with inositol polyphosphate 1-phosphatase | Involved in sulfate metabolism and inositol signaling |
| PAPSS1 | 3'-phosphoadenosine 5'-phosphosulfate synthase 1; related to PAP phosphatase | Indirectly affects inositol phosphate metabolism |
| PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2; related to PAP phosphatase | Indirectly affects inositol phosphate metabolism |
| GALM | Galactose mutarotase; not directly related but interacts with inositol metabolism | Potential cross-talk with galactose 1-phosphatase activity |
| GALK1 | Galactokinase 1; phosphorylates galactose | May share substrate overlap with inositol monophosphatase |
| GALE | UDP-galactose-4-epimerase; involved in galactose metabolism | Indirect link to inositol monophosphatase via galactose 1-phosphatase activity |
| PLCβ1 | Phospholipase C beta 1; generates inositol phosphates | Upstream of inositol monophosphate 1-phosphatase in signaling |
| PLCG1 | Phospholipase C gamma 1; produces inositol 1,4,5-trisphosphate | Regulates substrate availability for inositol phosphatases |
| PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha | Affects phosphatidylinositol pool and downstream inositol phosphates |
| PTEN | Phosphatase and tensin homolog; dephosphorylates phosphatidylinositol 3,4,5-trisphosphate | Indirectly influences inositol phosphate levels |
| SLC5A3 | Sodium/myo-inositol cotransporter; transports inositol into cells | Regulates intracellular inositol availability |
| SMIT1 | Sodium/myo-inositol cotransporter 1; same as SLC5A3 | Regulates inositol uptake |
| MIPS1 | Myo-inositol-1-phosphate synthase; synthesizes inositol monophosphate | Provides substrate for inositol monophosphate 1-phosphatase |
How Is inositol monophosphate 1-phosphatase activity Regulated?
Inositol monophosphate 1-phosphatase activity is regulated at multiple levels. Lithium acts as a non-competitive inhibitor by displacing magnesium from the active site, leading to reduced enzyme activity. Calcium and manganese ions also modulate activity, with calcium inhibiting and manganese activating the enzyme in some contexts [2,7]. Additionally, the expression of genes encoding these enzymes, such as IMPA1 and INPP1, can be regulated by hormonal and developmental signals, although specific transcription factors remain to be fully elucidated [6,8]. Post-translational modifications, including phosphorylation, may also influence enzyme activity, but direct evidence is limited.
inositol monophosphate 1-phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IMPA1 | Bipolar disorder; lithium response | Knockout mice, patient-derived iPSCs |
| IMPA2 | Schizophrenia; bipolar disorder | Knockout mice, neuronal cultures |
| INPP1 | Cancer; phosphatidylinositol signaling | Knockout cell lines, xenograft models |
| GALM | Galactosemia; inositol metabolism | Knockout mice, liver cells |
| SLC5A3 | Osmotic stress; inositol transport | Knockout mice, kidney cells |
Bipolar Disorder and Lithium Response
Inositol monophosphate 1-phosphatase is the proposed target of lithium, a mood stabilizer used in bipolar disorder. Inhibition of this enzyme by lithium reduces free inositol levels and dampens phosphatidylinositol signaling, which is thought to contribute to its therapeutic effects. Genetic variants in IMPA1 and IMPA2 have been associated with bipolar disorder and lithium response in some studies, although results are not consistent.
Schizophrenia and Neurodevelopmental Disorders
Alterations in inositol monophosphatase activity have been implicated in schizophrenia and other neurodevelopmental disorders. Postmortem studies have shown reduced IMPA2 expression in the brains of schizophrenia patients, and polymorphisms in IMPA2 have been linked to disease susceptibility. However, the exact mechanisms remain unclear and require further investigation.
Cancer and Cell Proliferation
Inositol polyphosphate 1-phosphatase, which also exhibits inositol monophosphate 1-phosphatase activity, plays a role in regulating phosphatidylinositol signaling, a pathway frequently dysregulated in cancer. Loss of INPP1 function may lead to altered inositol phosphate levels and enhanced cell proliferation, although direct evidence in human cancers is limited.
Galactosemia and Metabolic Disorders
Brain inositol monophosphatase has been identified as a galactose 1-phosphatase, suggesting a link between inositol metabolism and galactose metabolism. This dual activity may be relevant to galactosemia, a metabolic disorder characterized by galactose accumulation, but the clinical significance is not fully understood.
From inositol monophosphate 1-phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of IMPA1 loss on neuronal signaling? | IMPA1 knockout mice or iPSC-derived neurons |
| How does lithium inhibit inositol monophosphatase? | Point mutation of active-site residues in IMPA1 |
| Can we rescue bipolar disorder phenotypes by restoring IMPA1? | Knock-in of wild-type IMPA1 in patient cells |
| What is the role of INPP1 in cancer cell proliferation? | INPP1 knockout cancer cell lines |
| How does overexpression of IMPA2 affect inositol levels? | IMPA2 overexpression in HEK293 cells |
| What are the off-target effects of lithium on inositol phosphatases? | CRISPR library screening for lithium resistance |
How to Study the inositol monophosphate 1-phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Colorimetric phosphate assay | Inorganic phosphate release | Enzyme kinetics and inhibitor screening |
| X-ray crystallography | Three-dimensional structure | Active-site mapping and drug design [3,4] |
| CRISPR-Cas9 knockout | Gene function loss | Phenotypic analysis in cells and mice |
| Site-directed mutagenesis | Effect of specific mutations | Validation of catalytic residues |
| RNA-seq | Transcriptome changes | Pathway analysis upon gene manipulation |
| Proteomics | Protein expression and modifications | Identification of interacting partners |
| Fluorescence microscopy | Subcellular localization | Tagged enzyme tracking in live cells |
Biochemical Assays for Enzyme Activity
Inositol monophosphate 1-phosphatase activity can be measured using colorimetric or fluorometric assays that detect the release of inorganic phosphate from inositol monophosphate [1,7]. These assays are typically performed with purified enzyme or cell lysates and require the addition of magnesium or zinc ions for optimal activity. Lithium inhibition can be assessed by adding lithium chloride to the reaction.
Structural Biology and Crystallography
X-ray crystallography has been used to determine the three-dimensional structures of inositol polyphosphate 1-phosphatase and inositol monophosphatase, revealing the active-site architecture and metal-binding sites [3,4,5]. These studies provide a framework for understanding substrate specificity and inhibitor design. Site-directed mutagenesis combined with crystallography can validate the roles of key residues.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 can be used to generate knockout, point mutation, knock-in, and overexpression models to study the function of genes encoding inositol monophosphate 1-phosphatase activity. For example, knockout of IMPA1 in cell lines or mice can reveal its role in inositol homeostasis and lithium response. Point mutations can mimic disease-associated variants, while knock-in of tagged versions allows for localization and interaction studies.
Transcriptomics and Proteomics
RNA sequencing (RNA-seq) and mass spectrometry-based proteomics can be used to profile changes in gene and protein expression upon manipulation of inositol monophosphate 1-phosphatase activity. These approaches can identify downstream signaling pathways and compensatory mechanisms. Bioinformatics analysis of public datasets can also reveal correlations with disease states.
How CRISPR Can Be Used to Study GO:0008934 inositol monophosphate 1-phosphatase activity
Knockout
CRISPR-Cas9 knockout of genes such as IMPA1 or INPP1 can completely abolish inositol monophosphate 1-phosphatase activity, allowing researchers to study the consequences on inositol levels, signaling, and cellular phenotypes. Knockout cell lines and animal models are valuable for assessing the role of these enzymes in development, neuronal function, and disease.
Point Mutation
Introducing specific point mutations in the active site of IMPA1 or INPP1 via CRISPR can mimic naturally occurring variants or disrupt catalytic residues, enabling structure-function studies and validation of disease-associated mutations [4,8]. This approach helps distinguish between loss-of-function and gain-of-function effects.
Knock-in
Knock-in of tagged versions of inositol monophosphatase (e.g., GFP or FLAG) using CRISPR allows for real-time tracking of protein localization, interaction, and dynamics in live cells. Knock-in of disease-relevant mutations can also create isogenic models for drug testing.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression constructs can be used to increase the expression of IMPA1 or INPP1, enabling studies of gain-of-function effects and rescue experiments. Overexpression models are useful for assessing the impact of elevated enzyme activity on inositol recycling and signaling.
How EDITGENE Supports inositol monophosphate 1-phosphatase activity Research
Researchers studying inositol monophosphate 1-phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models, as well as high-throughput library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for inositol monophosphate 1-phosphatase activity research.
Frequently Asked Questions About inositol monophosphate 1-phosphatase activity
What is inositol monophosphate 1-phosphatase activity?
It is the enzymatic activity that removes a phosphate group from inositol monophosphate to produce free inositol and phosphate, encoded by GO:0008934 [1,2].
What genes are involved in inositol monophosphate 1-phosphatase activity?
Key genes include IMPA1, IMPA2, IMPA3, and INPP1, which encode enzymes with this activity [2,6].
How is inositol monophosphate 1-phosphatase activity regulated?
It is inhibited by lithium and modulated by magnesium, calcium, and manganese ions [2,7].
What diseases are associated with inositol monophosphate 1-phosphatase activity?
It has been linked to bipolar disorder, schizophrenia, cancer, and galactosemia [2,6,8].
What is the role of lithium in inositol monophosphate 1-phosphatase activity?
Lithium inhibits the enzyme by competing with magnesium, which is thought to underlie its mood-stabilizing effects.
How can I study inositol monophosphate 1-phosphatase activity?
You can use biochemical assays, structural biology, and CRISPR-based genome editing to manipulate and measure activity [1,3,8].
What are the substrates of inositol monophosphate 1-phosphatase?
The primary substrate is 1D-myo-inositol 1-phosphate, but some enzymes also hydrolyze inositol polyphosphates [2,5].
Is inositol monophosphate 1-phosphatase activity conserved across species?
Yes, the enzyme and its activity are conserved from bacteria to humans, with structural similarities [3,4].
What are the cofactors required for inositol monophosphate 1-phosphatase activity?
Magnesium or zinc ions are typically required for catalysis [1,4].
How does inositol monophosphate 1-phosphatase activity affect cell signaling?
It regulates the recycling of inositol, which is essential for phosphatidylinositol signaling and membrane trafficking [2,6].
Conclusion
Inositol monophosphate 1-phosphatase activity (GO:0008934) is a fundamental enzymatic function that maintains inositol homeostasis and supports phosphatidylinositol signaling. Its inhibition by lithium and its implication in psychiatric and neurological disorders make it a compelling target for research. Advances in CRISPR-based models and structural biology continue to unravel its molecular mechanisms and disease relevance. EDITGENE offers a full suite of services to facilitate this research, from gene editing to bioinformatics.
References
- 1. Fujimoto S et al.. 1996. Zinc-ion-dependent acid phosphatase exhibits magnesium-ion-dependent myo-inositol-1-phosphatase activity.. Biol Pharm Bull 19(6):882-5 PMID: 8799493
- 2. Inhorn RC et al.. 1987. Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+.. J Biol Chem 262(33):15946-52 PMID: 2824473
- 3. Faisal Tarique K et al.. 2014. Structure-based identification of inositol polyphosphate 1-phosphatase from Entamoeba histolytica.. Acta Crystallogr D Biol Crystallogr 70(Pt 11):3023-33 PMID: 25372691
- 4. York JD et al.. 1994. Crystal structure of inositol polyphosphate 1-phosphatase at 2.3-A resolution.. Biochemistry 33(45):13164-71 PMID: 7947723
- 5. Faisal Tarique K et al.. 2014. Structural elucidation of a dual-activity PAP phosphatase-1 from Entamoeba histolytica capable of hydrolysing both 3'-phosphoadenosine 5'-phosphate and inositol 1,4-bisphosphate.. Acta Crystallogr D Biol Crystallogr 70(Pt 7):2019-31 PMID: 25004978
- 6. Parthasarathy R et al.. 1997. Brain inositol monophosphatase identified as a galactose 1-phosphatase.. Brain Res 778(1):99-106 PMID: 9462881
- 7. Attwood PV et al.. 1988. Purification and properties of myo-inositol-1-phosphatase from bovine brain.. Biochem J 253(2):387-94 PMID: 2845918
- 8. York JD et al.. 1990. Isolation and heterologous expression of a cDNA encoding bovine inositol polyphosphate 1-phosphatase.. Proc Natl Acad Sci U S A 87(24):9548-52 PMID: 2175905
